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Current management attempts for Alzheimer’s disease (AD) focus on the iden-tification of individuals in the preclinical stage. This has led to the develop-
ment of the diagnostic concept of Mild Cognitive Impairment (MCI), which applies
to individuals with declining cognitive abilities but largely preserved everyday
functioning. Previous findings indicate that prospective memory deficits are a sen-
sitive marker of preclinical AD and that awareness of prospective memory failures
is particularly high, based on its dependence on executive functions. Thus, the
goal of this study was to evaluate the usefulness of subjective prospective versus
retrospective memory complaints for an initial screening for MCI and their
respective associations with executive functions. 71 healthy older adults, 27 MCI
patients, and 9 patients with mild AD completed the Prospective and
Retrospective Memory Questionnaire (PRMQ) and three executive functions
tests. The healthy and the MCI group could not be distinguished by their level of
subjective prospective or retrospective memory complaints, but the mild AD
patients differed from the other groups by complaining more about retrospective
than prospective memory failures. For the healthy older adults, the prospective
memory complaints were correlated to an inhibition test, whereas they did not
correlate with any of the executive function tests in the MCI patients. In contrast,
in both groups the retrospective memory complaints were related to a task
switching test. The findings are discussed with respect to differences between the
three groups in cognitive abilities, attention to failures of, use of mnemonic aids
for, and everyday demands of prospective and retrospective memory.
Keywords: subjective cognitive complaints, prospective memory, mild cognitive impairment, Alzheimer’s
disease
With growing life expectancy, Alzheimer’s disease
(AD) has become a major health challenge for
industrialised countries (Sloane, Zimmerman,
Suchindran, Reed, Wang et al., 2002). Clinical
diagnosis of AD requires the presence of multiple
cognitive deficits and impairment of everyday
functioning (see 4th edition of the Diagnostic and
Statistical Manual for Mental Disorders, DSM-IV;
American Psychiatric Association, 1994). This has
been considered as a very late stage for possible
therapeutic intervention in the neuropathological
process (Reisberg & Gauthier, 2008) and, there-
fore, current management attempts focus on the
identification of individuals in the transitional
state between normal ageing and AD charac-
terised by first cognitive impairments, but still
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largely preserved functional abilities (Caselli,
Beach, Yaari, & Reiman, 2006; Leifer, 2003).
Among diagnostic concepts developed for this
purpose (see Reisberg, Ferris, Kluger, Franssen,
Wegiel et al., 2008 for an overview), Mild
Cognitive Impairment (MCI) as proposed by the
International Working Group on Mild Cognitive
Impairment (Winblad et al., 2004) has lately
achieved the most general acceptance. However, it
has been criticised for its heterogeneity
(Rockwood, Chertkow, & Feldman, 2007):
although there is a markedly higher incidence of
AD in individuals with MCI as compared to the
general population (Petersen & Negash, 2008), a
rather high percentage develops other dementias,
remains stable, or even reverts to a cognitively
intact status (Ganguli, 2006). Furthermore, preva-
lence of MCI and conversion rates to AD vary
between different studies, caused by differences in
populations being studied (clinic attenders or
normal population) and in specific operationalisa-
tion of MCI criteria (Bruscoli & Lovestone, 2004;
Panza, D’Introno, Colacicco, Capurso, Del Parigi
et al., 2005).
Diagnostic criteria for MCI are (a) the person is
neither normal nor demented, (b) there is evidence
of cognitive deterioration shown by either decline in
neuropsychological test performance over time
and/or subjective report of decline by self and/or
informant in conjunction with objective cognitive
deficits as defined by neuropsychological test per-
formance below age-adjusted norms, and (c) activi-
ties of daily living are preserved and complex
instrumental functions are either intact or minimally
impaired. As for AD diagnosis, other causes for cog-
nitive dysfunction have to be excluded. For first
diagnostic assessment of MCI a stepwise procedure
is recommended: first the examination of cognitive
complaints by the person assessed or a close
acquaintance of this person, then the assessment of
the person’s cognitive and functional abilities. Since
information from an acquaintance takes time and
might be difficult to acquire, the question arises
whether self-reported cognitive deficits constitute a
useful initial screening for MCI.
Such a screening should distinguish MCI
patients from healthy older adults as well as from
mild AD patients. Studies with elderly population-
based samples (Fisk, Merry, & Rockwood, 2003;
Fisk & Rockwood, 2005; Jungwirth, Fischer,
Weissgram, Kirchmeyr, Bauer et al., 2004; Luck,
Busse, Hensel, Angermeyer, & Riedel-Heller, 2008;
Purser, Fillenbaum, & Wallace, 2006) question the
ability of self-reported cognitive impairments to dis-
criminate MCI patients from healthy older adults.
They demonstrated that about as many people with
cognitive impairments and largely preserved every-
day functioning complained about cognitive impair-
ments as not. Furthermore, many people with
normal cognitive and functional abilities also com-
plained about cognitive deficits.
However, in these studies subjective cognitive
complaints were assessed with a single question
regarding memory impairment that seems to be
inappropriate with regard to its specificity and sensi-
tivity for MCI. Cognitive impairment indicative for
MCI is defined by neuropsychological test perfor-
mance below age-adjusted norms. However, normal
ageing is associated with mild cognitive decline and
thus many older adults will judge their memory as
impaired. On the other hand, since MCI patients
may experience deficits in other cognitive domains
than memory and do not show impairments in most
aspects of everyday functioning, many of them will
judge their memory as intact. Therefore, a screening
instrument for subjective cognitive complaints sug-
gestive for MCI should rather include several ques-
tions regarding different aspects of cognitive
functioning and differences between MCI patients
and healthy older adults should arise in their level of
positive answers or ratings. The same holds true for
the differentiation between MCI and mild AD
patients, because they also only differ in their level
of cognitive and functional impairment.
Indeed, several studies using questionnaires or
interviews about everyday impairments in memory
(Clément, Belleville, & Gauthier, 2008; De Jager &
Budge, 2005; Perrotin, Belleville, & Isingrini, 2007)
or in several cognitive domains (Kliegel, Zimprich,
& Eschen, 2005; Rabin et al., 2006) have demon-
strated that MCI patients report a higher level of sub-
jective cognitive complaints than healthy older
adults, but a similar level of subjective memory
(Clément et al., 2008) or general cognitive com-
plaints (Kalbe et al., 2005) as mild AD patients.
The latter findings have been explained with
the diminished insight of the mild AD patients in
their cognitive deficits. On cognitive question-
naires, they evaluate their cognitive abilities as
more positive than their carers (e.g.,, Cahn-
Weiner, Ready, & Malloy, 2003; Derousné et al.,
1999). However, findings by Vogel, Hasselbach,
Gade, Ziebell, and Waldemar (2005) also question
insight of MCI patients: in comparison with their
carers, MCI patients underreported their cognitive
deficits to a similar degree as mild AD patients. In
contrast, Kalbe and colleagues (2005) found MCI
patients to over- and mild AD patients to underre-
port their cognitive impairments.
These differential findings might be caused by
differences in the instruments used. Kalbe and col-
leagues questioned their participants on various
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cognitive abilities, while Vogel and colleagues
used a memory questionnaire only, suggesting
that MCI patients have a diminished insight for
this cognitive ability specifically. This is surpris-
ing, since episodic memory impairment is one of
the earliest and best cognitive predictors of AD
(Almkvist, 1996; Bäckman, Jones, Berger,
Laukka, & Small, 2005; Rubin et al., 1998) and
the MCI patients in Vogel and colleagues’ study
had a severe impairment in this cognitive domain
only. Kalbe and colleagues, however, did not find
significant differences between the MCI and AD
patients’ and their caregivers’ ratings for their
memory question. Clément and colleagues (2008)
reported that although their MCI and mild AD
patients had similar sum scores on a memory
questionnaire, the AD patients had significantly
higher scores than their healthy older sample on 3
of 10 questionnaire subsections referring to differ-
ent memory types, whereas the MCI patients had
significantly higher scores than the healthy older
adults on these and three additional subsections.
This suggests that only questionnaires on certain
types of memory impairments might be useful to
discriminate between healthy older adults, MCI
patients, and mild AD patients.
Research on episodic memory impairment in
AD has so far mainly concentrated on one of its
domains, that is, retrospective memory, whereas
prospective memory has largely been neglected.
While retrospective memory relates to remember-
ing past events, prospective memory refers to
remembering to carry out planned actions at pre-
specified times in the future (McDaniel & Einstein,
2007). Prospective memory has a retrospective
component (remembering which actions were
intended for what times), but involves distinct pro-
cesses (termed prospective component) that enable
self-initiated punctual action execution (for verifi-
cation of discriminant validity of prospective
versus retrospective memory see Salthouse, Berish,
& Siedlecki, 2004 and Zeintl, Kliegel, & Hofer,
2007). Among these distinct processes, executive
functions, such as monitoring for execution times
while performing other activities, inhibition of
ongoing activities, and initiation of the planned
actions at the critical times, seem to play a leading
role (for detailed task analyses see Burgess &
Shallice, 1997; Ellis, 1996; Knight, 1998; for evi-
dence on greater involvement of executive func-
tions versus retrospective memory see Kopp &
Thöne-Otto, 2003; McDaniel, Glisky, Rubin,
Guynn, & Routhieaux, 1999).
To date, only a few studies have compared the
sensitivity of prospective and retrospective
memory as an early indicator of AD. Maylor,
Smith, Della Sala, and Logie (2002) found that
individuals with mild to moderate AD performed
worse than healthy controls on prospective
memory tasks, but were even more impaired on
retrospective memory tasks. Surprisingly, the ret-
rospective component of the prospective memory
task was intact in all their AD patients. Duchek,
Balota, and Cortese (2006) also demonstrated a
clear prospective memory deficit relative to
healthy controls in older adults with very mild
AD. The authors did not directly compare prospec-
tive and retrospective memory performance of their
participants, but demonstrated that the prospective
memory performance helped to discriminate
between the very mild AD patients and healthy
adults above and beyond retrospective memory
performance. Moreover, within their prospective
memory task, the AD patients’ impairment was
greater for the prospective than for the retrospec-
tive component. Finally, in a large longitudinal
population-based study, Jones, Livner, and
Bäckman (2006) found that compared to partici-
pants who remained healthy, participants who three
years later received an AD diagnosis showed simi-
lar deficits in prospective and retrospective
memory. Additionally, their impairments in the ret-
rospective and the prospective component of the
prospective memory task were of equal size. In
summary, these findings indicate that prospective
memory is a similarly sensitive marker of preclini-
cal or early AD as retrospective memory.
With regard to subjective memory complaints,
prospective memory complaints may have a
higher discriminative power than retrospective
memory complaints for MCI. Mäntylä (2003)
suggested that people are more aware of their
prospective than their retrospective memory fail-
ures because prospective memory tasks involve
more executive and thus conscious, self-initiated
behaviour and are, therefore, more often subject to
conscious perception and evaluation processes.
Furthermore, people may monitor their prospec-
tive memory performance more closely than their
retrospective memory performance since prospec-
tive memory failures seem to cause a greater
impairment in everyday functioning (Kliegel &
Martin, 2003) and have more negative social con-
sequences — they are attributed to a person’s lack
of reliability, whereas retrospective memory fail-
ures are ascribed to a weakness of a person’s
memory (Winograd, 1988).
With the Prospective and Retrospective
Memory Questionnaire (PRMQ; Smith, Della
Sala, Logie, & Maylor, 2000), a questionnaire
specifically developed for capturing differences
between subjective prospective and retrospective
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memory complaints, a greater awareness for
prospective than for retrospective memory fail-
ures has been consistently found in the normal
population (Crawford, Smith, Maylor, Della Sala,
& Logie, 2003; Kliegel & Jäger; 2006; Mäntylä,
2003; Rönnlund, Mäntylä, & Nilsson, 2008;
Singer, Falchi, MacGregor, Clerkas, & Spector,
2006; Smith et al., 2000). Furthermore, Singer and
colleagues (2006) could demonstrate a specific
association of subjective prospective memory
complaints with executive functions: in a large
sample of healthy twins the PRMQ Prospective
Scale was not correlated to classical retrospective
memory tasks, but to a working memory task
only. However, Smith and colleagues (2000)
found the PRMQ Prospective and Retrospective
Scales to discriminate AD patients from healthy
older adults equally well. Nevertheless, Smith and
colleagues had asked the carers of their AD
patients to complete the PRMQ on the patients’
behalf and the objectivity of the carers’ judgement
was questioned by the finding that the carers eval-
uated their own everyday prospective and retro-
spective memory better than age-matched healthy
control participants.
Therefore, the first aim of this study was to eval-
uate the usefulness of self-reported prospective
versus retrospective memory complaints as an initial
screening for MCI by comparing the ratings of a
group of healthy older adults, a group of MCI
patients, and a group of mild AD patients on the
Prospective and the Retrospective Scale of the
PRMQ. It was anticipated that all participant groups
complain more about prospective than retrospective
memory failures. MCI patients were expected to
report more prospective and retrospective memory
failures than the healthy older adults, while the AD
patients were expected to report more prospective
memory failures than the MCI patients, but a similar
amount of retrospective memory failures.
The second aim of this study was to evaluate
Mäntylä’s claim that greater awareness of everyday
prospective than retrospective memory competence
is based on its greater dependence on executive
functioning and whether this applies to healthy older
adults as well as to MCI patients for whom insight
in their memory competence has been questioned.
This was done by calculating correlations between
the scores of the healthy older adults or MCI
patients, respectively, on the PRMQ Prospective and
Retrospective Scales and on three executive func-
tion tests. It was expected that for both healthy older
adults and MCI patients, at least one of the executive
function tests would be correlated to the Prospective
Scale, but none to the Retrospective Scale.
Method
Participants
In total, 107 participants were included in the
analyses: 27 MCI patients, 9 patients with mild
AD, and 71 healthy older controls.
MCI and AD Patients
The MCI and AD patients were recruited out of
311 in- and outpatients of the Gerontopsychiatric
Centre of the Psychiatric University Hospital
Zurich who underwent a neuropsychological
examination as part of an extensive diagnostic
assessment for self- or informant-reported cogni-
tive decline between July 2003 and June 2005 for
the first time. At the end of the neuropsychologi-
cal examination, patients who were not handi-
capped by too severe perception, language, or
comprehension impairments were asked to com-
plete the PRMQ. In total, 101 patients were able
to and agreed to fill out the questionnaire.
The neuropsychological test battery (see
below) contained a depression screening question-
naire and tests for the cognitive domains memory,
language, praxia, perception, executive functions,
attention, speed, and crystallised intelligence.
Cognitive impairment was operationalised by test
performance of at least one standard deviation
below age-adjusted norms, since MCI diagnosis
based on this cut-off score has been found to have
the highest predictive power for later development
of dementia (Busse, Hensel, Gühne, Angermeyer,
& Riedel-Heller, 2006). In addition to the neu-
ropsychological examination, a clinical interview
with the patient and a person who knew the patient
well was conducted to determine the patient’s
level of functional ability, to evaluate the presence
of psychiatric disorders including substance
abuse, and to obtain a medical history. The medi-
cal history was corroborated by and comple-
mented with relevant previous medical reports
about the patient. Furthermore, a neurological, a
neuroradiological (either computer tomography or
magnetic resonance imaging), and a laboratory
examination were conducted to screen for neuro-
logical and systemic diseases known to cause
cerebral dysfunction. Based on the assessment
results, patients were diagnostically classified by a
consensus conference of the multidisciplinary
clinic staff.
Out of the 101 patients who completed the
PRMQ, 9 received the diagnosis of a probable
AD according to the DSM-IV (American
Psychiatric Association, 1994) and the NINCDS-
ADRA criteria (McKhann et al., 1984), and 27
received the diagnosis of MCI according to the
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general MCI criteria as proposed by the
International Working Group on Mild Cognitive
Impairment (Winblad et al., 2004). All AD
patients were in the mild stage of the disease as
indicated by MMSE scores greater than 17 and
by their individual neuropsychological profiles,
that is their cognitive impairments were
restricted to memory, naming, executive func-
tions, and constructional praxia deficits (Ballard
et al., 1999; Storey, Slavin, & Kinsella, 2002).
Like AD, MCI was only diagnosed when there
was no evidence for neurological and systemic
diseases, psychiatric disorders, or substance
abuse that could account for the cognitive
deficits. The remaining 65 patients who com-
pleted the PRMQ were excluded from the analy-
ses for the following reasons: 1 did not complete
the whole assessment procedure, 3 showed normal
test performance, 1 had a schizoaffective disorder,
16 for indication of a depressive episode (either by
clinical diagnosis or by the scores on the depres-
sion screening questionnaire), 10 for alcohol
abuse, 3 for epilepsy, 1 for a traumatic brain
injury, 1 for a subdural hematoma, 12 for strokes
or cerebrovascular haemorrhages, 2 suffered from
a subcortical vascular dementia, 11 from a mixed
dementia, and 4 from Parkinson’s disease. Figure
                              
311 patients with neuropsychological examination
for self- or informant- reported cognitive decline
210 unable or
disagreed to
complete
PRMQ
98 one SD below
age-adjusted norms
Neuropsychological
test performance
3 greater than one
SD below age-
adjusted norms
1 withdrewWhole diagnostic
assessment
34 neurological
diseases
17 psychiatric
disorders
10 alcohol abuse
Other neurological,
systemic, or
psychiatric illnesses,
or substance abuse
Final diagnosis
(everyday
functioning +
cognitive profile)
9 mild AD
(impaired everyday
functioning +
typical cognitive
profile)
36 no evidence
27 MCI
(mostly preserved
everyday functioning
+ mild cognitive
deficits)
101 completed
97 completed
FIGURE 1 
Selection procedure for the MCI and the mild AD patients.
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1 shows a schematic overview of the diagnostic
procedure for the MCI and the mild AD patients.
Healthy Older Controls
Altogether 80 community-dwelling older adults
aged between 54 and 91 years (in order to match
for the typical patient age range of the
Gerontopsychiatric Centre) were recruited as con-
trols. They were screened with the help of a
specifically designed health questionnaire and a
depression screening questionnaire (see below) for
the same exclusion criteria that were applied for
the diagnosis of the MCI and AD patients: regular
use of neurotoxic substances or neurological, psy-
chiatric, and systemic diseases known to cause
cognitive dysfunction. With this procedure, nine
participants were excluded: five for indication of
alcohol abuse and four for indication of a depres-
sive episode (either by relevant information from
the health questionnaire or by the scores on the
depression screening questionnaire).
Materials
Depression Screening Questionnaires
For the patients the short form of the Geriatric
Depression Scale (GDS; Sheikh & Yesavage,
1986) was used to screen for the presence of a
depressive episode, whereas for the healthy
elderly volunteers the depression subscale of the
Hospital Anxiety and Depression Scale (HADS;
Zigmond & Snaith, 1983) was applied. Both
questionnaires focus on emotional and motiva-
tional depressive symptoms, thus avoiding over-
lap with somatic symptoms common in ageing.
The GDS was chosen for the mostly cognitively
impaired patients because of its easy response
format (yes/no-format). For the healthy older
adults, the HADS depression subscale was
chosen because it has a greater score range and
allows for graded responses to single items and
therefore was expected to lead to a more accurate
identification of depressive cases.
Short form of the Geriatric Depression Scale
(GDS). It includes 15 questions that can be
agreed or disagreed to. Answers indicative of a
depressive episode are summed up. Possible
minimum and maximum scores are 0 and 15.
Sum scores greater than 5 are considered to be
suggestive, scores greater than 10 to be indica-
tive of the presence of a depressive episode.
GDS scores greater than 5 lead to exclusion
from this study. All patients completed the GDS
in the presence of their neuropsychologist and
were thus able to ask comprehension questions.
The depression subscale of the Hospital
Anxiety and Depression Scale (HADS). It con-
tains seven items (e.g., ‘I have lost interest in
my appearance’). Participants have to indicate
on a 4-point rating scale (nearly all of the time,
very often, sometimes, not at all) how often
these symptoms occurred in the last week.
These ratings are assigned numerical values of 3
(nearly all of the time) to 0 (not at all) and
summed up. Consequently, possible scores
range from 0 to 21. Scores between 8 and 10 are
regarded as suggestive, scores of 11 and higher
as indicative of the presence of a depressive
episode. In this study, scores greater than 7 lead
to exclusion. All healthy volunteers completed
the HADS depression subscale in the presence
of the experimenter and were thus able to ask
comprehension questions.
Neuropsychological Tests
MCI and AD patients. The neuropsychological
examination for the MCI and AD patients
included the German version of the Consortium
to Establish a Registry for Alzheimer’s disease
Neuropsychological Assessment Battery
(CERAD-NAB) that was scaled on a large Swiss
German sample of healthy adults aged between
53 and 92 years to provide age-, gender-, and
education-specific norms (Berres, Monsch,
Bernasconi, Thalmann, & Stähelin, 2000). It has
been proven to discriminate between healthy
older adults, patients with a major depression,
with MCI, with mild, and with moderate AD,
respectively (Barth, Schönknecht, Pantel, &
Schröder, 2005) as well as between patients with
mild AD, mild frontotemporal dementia, and
mild semantic dementia (Diehl et al., 2005). The
CERAD-NAB contains seven subtests: the Mini-
Mental State Examination (MMSE; Folstein,
Folstein, & McHugh, 1975), a semantic fluency
test, a 15-item form of the Boston Naming Test,
a constructional praxia test, a visual delayed free
recall test, a word list learning test, a delayed free
recall, and a delayed recognition test for this
word list.
All participants. The following tests were com-
pleted by all participant groups. They were
selected from the neuropsychological test bat-
tery for the MCI and AD patients, to allow for a
short measurement of crystallised intelligence
and executive functioning (i.e., working
memory, task switching, and inhibition) in the
healthy older adults.
• Crystallised intelligence was evaluated with
the Mehrfachwahlwortschatztest B (MWT-
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B; Lehrl, 1977), a multiple-choice vocabu-
lary test. Raw scores can be converted to IQ
scores. Since crystallised intelligence is
thought to be a product of both formal and
informal educational efforts throughout life
(see Cattell, 1987), this test was used as a
second measure for educational attainment
next to years of schooling which reflect by
definition only formal educational efforts in
the youth.
• Working memory was tested with the Digit
Span backward subtest of the German ver-
sion of the Wechsler Memory Scale-Revised
(WMS-R; Härting et al., 2000). Possible
minimum and maximum scores are 0 and 12.
• Task switching was measured with the Trail
Making Test (TMT; Reitan, 1955; version
and norms according to the new extended
German CERAD-NAB online version
‘CERAD-Plus online’, Memory Clinic
Basel). In Part A of the TMT (TMT-A), the
time (in s) was measured that the partici-
pants needed to connect randomly dis-
tributed digits (1–25) in ascending order.
This is regarded as a measure for motor
speed. In Part B of the TMT (TMT-B) the
time (in s) was measured that the partici-
pants needed to alternately connect ran-
domly distributed digits (1–13) and letters
(A–L) in ascending or alphabetical order,
respectively. In the ‘CERAD-Plus online’
— TMT version the quotient of time for Part
B and time for Part A (TMT B/A) is used as
a measure for task switching, thus control-
ling for motor speed.
• Inhibition was measured with the third plate
of the Stroop-Victoria Test (Regard, 1981).
The third plate depicts the words ‘yellow’,
‘red’, ‘blue’, and ‘green’ (altogether 20) in
the yellow, red, blue, and green with the
colour of the words not corresponding to
their meaning. The time (in s) was measured
that the participants need to correctly state
the colour of all words.
Prospective and Retrospective 
Memory Complaints
For the assessment of the amount of prospective
and retrospective memory complaints, all par-
ticipants completed the German version of the
PRMQ (Kaschel, 2002; original version by
Smith et al., 2000). The PRMQ contains 16
items. Eight of these items refer to everyday
prospective memory failures (e.g., ‘Do you fail
to mention or give something to a visitor that
you were asked to pass on?’) and form the
Prospective Scale. The 8 other items refer to
everyday retrospective memory failures (e.g.,
‘Do you fail to recognise a place you have vis-
ited before?’) and form the Retrospective Scale.
The questions on both scales are matched for
two other dimensions of episodic memory (i.e.,
self- versus environmentally-cued retrieval and
length of retention interval). On each item, one
can indicate on a 5-point Likert-type rating
scale (very often, quite often, sometimes, rarely,
and never) how often one has recently experi-
enced this particular memory failure. These rat-
ings are assigned numerical values of 5 (very
often) to 1 (never) and are summed up.
Consequently, possible minimum and maxi-
mum scores on the Prospective and Retrospec -
tive Scales are 8 and 40.
Confirmatory factor analyses on the PRMQ
items in a large British (Crawford et al., 2003)
and in a large Swedish (Rönnlund et al., 2008)
population-based sample have indeed proven a
three-factor structure of the PRMQ, with the
Prospective and Retrospective Scales as orthog-
onal factors and episodic memory as a common
factor. These studies also confirmed a high reli-
ability of both scales (Crawford et al.:
Cronbach’s alphas were 0.84 and 0.80;
Rönnlund et al.: Cronbach’s alphas were 0.86.
and 0.78 for the Prospective and Retrospective
Scales, respectively). Additionally, concurrent
validity of the Prospective Scale has been
demonstrated: in healthy middle-aged (Mäntylä,
2003) and older adults (Kliegel & Jäger, 2006;
Zeintl, Kliegel, Rast, & Zimprich, 2006), per-
formance on laboratory prospective memory
tasks was correlated to the PRMQ Prospective
Scale. Moreover, Mäntylä (2003) could provide
evidence that the Prospective Scale is indeed
related to everyday prospective memory perfor-
mance. He demonstrated that middle-aged
women who specifically regarded their prospec-
tive memory as poor had higher scores than
middle-aged women who considered their
memory generally as intact only on the
Prospective Scale. Additionally, the complain-
ing women performed equally well as the non-
complaining women on classical retrospective
memory tasks, but were slightly impaired on
laboratory and severely impaired on naturalistic
prospective memory tasks.
All MCI and AD patients completed the
PRMQ in the presence of their neuropsycholo-
gist; all healthy older adults in the presence of
the experimenter. All participants were thus
able to ask comprehension questions.
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Results
Excluded Participants
Excluded Patients
There were no differences between excluded
patients (n = 65) and the included MCI and mild AD
patients (n = 36) in age, t(99) = –0.34, p < .80; years
of schooling, U(65) = 412.5, p < .20; crystallised
intelligence, U(84) = 814.0, p < .80; MMSE scores,
U(100) = 981.5, p < .30; PRMQ Prospective, t(98) =
1.30, p < .30; and Retrospective Scale scores, t(96)
= 0.20, p < .90. There was a significantly lower pro-
portion of women, 53.8% vs. 75.0%, χ2(1, N = 101)
= 4.37, p = .036, and a trend towards a lower pro-
portion of outpatients, 69.2% vs. 86.1%, χ2(1, N =
101) = 3.54, p = .060) in the excluded patient group.
They had significantly higher Geriatric Depression
Scale scores than the included patients (Mdn = 6.0,
range = 15 vs. Mdn = 2.0, range = 5), U(99) = 373.0,
p < .001.
Excluded Healthy Controls
There were no differences between excluded (n =
9) and included healthy control participants (n =
71) in age, t(78) = –0.79, p < .50; gender, χ2(1, N
= 80) = 2.16, p = .141; crystallised intelligence
t(78) = –0.58, p < .60; PRMQ Prospective, t(78) =
–0.90, p < .40; and Retrospective Scale scores,
t(77) = –0.74, p < .50. The excluded healthy par-
ticipants had more years of schooling (M = 15.00,
SD = 2.50 vs. M = 13.30, SD = 2.86) and higher
HADS depression subscale scores than the
included healthy controls (M = 5.22, SD = 3.11 vs.
M = 3.08, SD = 1.75), but these differences just
failed to reach significance level, t(8.65) = 2.02, p
= .075; or t(78) = 1.71, p = .091, respectively.
Participant Groups Characteristics
Table 1 provides demographic data (age, gender,
years of schooling, crystallised intelligence)
about the three participant groups. For the MCI
patients and the mild AD patients additionally
GDS scores, proportion of outpatients, MMSE
scores, and CERAD-NAB memory subtest
scores are presented.
Demographic Variables
The three participant groups did not differ in age,
F(2, 104) = 0.36, p < .80, or gender, χ2(2, N = 107)
= 3.63, p < .20. There was a group difference with
respect to formal education, F(1,104) = 3.28, p =
.042, with post-hoc comparisons (Tukey a) indi-
cating a trend to fewer years of schooling in the
AD patients as compared to the healthy older
adults, HSD = –2.18, p = .087. A Kruskal-Wallis
test with participant group as between-subject
variable was used to evaluate group differences in
crystallised intelligence because variance homo-
geneity between groups was not given. According
to this analysis, χ2(2, N = 105) = 28.98, p < .001,
the groups differed in their crystallised intelli-
gence level. Post-hoc comparisons (independent t
tests) indicated that the healthy older adults had a
higher crystallised intelligence level than the
MCI, t(94) = 4.95, p < .001, and the AD patients,
TABLE 1
Participant Groups Characteristics 
Control MCI AD
(n = 71) (n = 27) (n = 9)
M (SD) M (SD) M (SD)
Age (years) 73.20 (7.34) 73.44 (6.84) 75.33 (6.56)
Proportion of women 59.2 % 70.4 % 88.9 %
Years of schooling 13.30 (2.86) 12.15 (3.27) 11.11 (1.54)
Intelligence (IQ)a 124.0 (52) 107.0 (50)b 104.0 (15)
GDS scores 2.02 (1.54) 2.22 (1.39)
Proportion of outpatients 88.9 % 77.8 %
MMSE 27.44 (2.08) 25.78 (3.53)
Word list learningc –1.34 (1.69) -2.48 (0.86)
Word list delayed free recallc –1.08 (1.48) -2.76 (0.60)
Word list delayed recognitionc –1.26 (2.60) -3.84 (2.76)
Visual delayed free recallc –0.79 (1.50) -1.87 (0.86)
Note: aMedians and ranges are reported because group variances were inhomogeneous. 
bn = 25. cCERAD-NAB subtests. In age-, gender-, and education-adjusted z scores.
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t(32.85) = 8.74, p < .001. The median crystallised
intelligence level of the healthy older adults was
above average and that of the MCI and the AD
patients approximately average, with all partici-
pants individually having at least an average IQ
(minimum IQ of the whole sample was 86). This
is in line with findings of higher incidence rates
for MCI (Kumar et al., 2006; Panza et al., 2005;
Tervo et al., 2004) and AD (see Caamaño-Isorna,
Corral, Montes-Martínez, & Takkouche, 2006 for
a meta-analysis) in older adults with lower educa-
tional attainment.
Depressivity
Due to the strict selection procedure (exclusion of
healthy older adults with scores greater than 7 on
the HADS depression subscale and of patients with
scores greater than 5 on the GDS), the reported
level of depressivity in all participant groups was
very low (for patient groups see Table 1; healthy
participants: mean HADS depression subscale
score = 3.08, SD = 1.75). The MCI and AD patients
did not differ in GDS scores, t(34) = –.35, p < .80.
Patient Status of MCI and AD Patients
The two patient groups did not differ in the relative
proportion of in- and outpatients, χ2(1, N = 36) =
0.68, p < .50. The large majority of the patients
were outpatients, indicating that most patients’
functional status was relatively mildly impaired.
General Cognitive Status of MCI and 
AD Patients
The MMSE scores of both patient groups were in
the range regarded as typical for MCI and mild
AD patients, that is for the MCI group between 24
and 30 and for the mild AD group between 18 and
30. The mean MMSE scores of the two patient
groups indicate a very mildly impaired general
cognitive status of the MCI patients and a mildly
impaired general cognitive status of the AD
patients. There was a trend towards higher MMSE
scores in the MCI patients, t(34) = 1.73, p = .092.
Retrospective Episodic Memory of MCI 
and AD Patients
Table 1 displays the CERAD-NAB memory sub-
test scores as age-, gender-, and education-
adjusted z scores according to the norms provided
by a large healthy elderly Swiss German sample,
thus allowing for comparison between the test
performances of the two patient groups and the
test performances of demographically-matched
healthy older adults. Compared to the healthy nor-
mative sample, as a group, the MCI patients
showed only mild verbal retrospective memory
impairments (mean CERAD-NAB word list sub-
tests z scores between one and two standard devi-
ations and mean CERAD-NAB visual free
delayed recall subtest z score within one standard
deviation below demographic-adjusted norms). In
contrast, the mild AD patients showed severe
verbal retrospective memory impairments (mean
CERAD-NAB word list subtests z scores below at
least two standard deviations below demographic-
adjusted norms) and additionally a mild visual ret-
rospective memory deficit (mean CERAD-NAB
visual free delayed recall subtest z score between
one and two standard deviations below demo-
graphic-adjusted norms). The MCI patients per-
formed significantly better than the mild AD
patients on all CERAD-NAB memory subtests;
word list learning: t(27.77) = 2.65, p = .013;
word list delayed free recall: t(32.41) = 4.83, p
< .001; word list delayed recognition: t(34) =
2.54, p = .016; visual delayed recall: t(24.80) =
2.62, p = .015.
Group Differences in Prospective and
Retrospective Memory Complaints
In Table 2, the mean PRMQ Prospective and the
mean Retrospective Scale scores for each of the
TABLE 2
Comparison of the Participants Groups for the PRMQ Prospective (PS) and Retrospective Scale (RS) Scores
Group n PS RS Average between  
M (SD) M (SD) PS and RS
M (SD)
Control 70 19.06 (4.38) 18.87 (4.24) 18.96 (4.41)
MCI 27 18.85 (5.82) 18.56 (4.82) 18.70 (4.41)
AD 9 17.22 (6.08) 20.56 (5.90) 18.89 (4.41)
Whole sample 106 18.93 (4.52) 18.85 (4.91) 18.85 (6.10)
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three participant groups and the whole sample are
presented. Additionally, in the last column of Table
2 the means for the average between the Prospective
and Retrospective Scale scores for each participant
group and the whole sample are provided.
A 3 × 2-mixed ANOVA with participant group
as between-subject factor and type of memory
complaint (i.e., Prospective versus Retrospective
Scale of the PRMQ) as within-subjects factor was
conducted to assess whether the participant
groups differed in the amount of prospective
versus retrospective memory complaints. The
main effect of group was not significant, F(2, 103)
= 0.03, p < .97, partial η2 = 0.001, indicating that
the groups did not differ in the amount of reported
memory failures (regardless of which type). As can
be seen in the last column of Table 2, the means for
of the average between the Prospective and
Retrospective Scale scores were very similar for all
groups. There was a main effect of type of memory
complain, F(1, 103) = 4.16, p = .044, partial η2 =
0.039. As can be seen in the last row of Table 2, the
mean Prospective Scale scores of the whole sample
were lower than the mean Retrospective Scale
scores of the whole sample. This indicates that in
the whole sample more retrospective than prospec-
tive memory failures were reported. Furthermore,
there was an interaction between participant group
and type of memory complaint, F(2, 103) = 4.33, p
= .016, partial η2 = 0.077. As can be deducted from
Table 2, the Prospective and Retrospective Scale
scores of the healthy older adults and the MCI
patients were very similar, whereas the
Retrospective Scale scores of the AD patients were
greater than their Prospective Scale scores. Post-
hoc paired t tests confirmed that there was no dif-
ference between the Prospective and Retrospective
Scale scores of the healthy older adults, t(69) =
–.55, p < .60, d = 0.04, and of the MCI patients,
t(26) = –.35, p < .80, d = 0.05), whereas this dif-
ference was marginally significant for the AD
patients, t(8) = 2.22, p = .057, d = –0.56.
Therefore, the main effect of greater
Retrospective than Prospective Scale scores was
probably mainly caused by the greater
Retrospective than Prospective Scale scores of the
AD patients. In conclusion, these analyses indi-
cate that the participant groups did not differ in
their mean level of prospective and retrospective
memory complaints. However, the AD patients
reported more retrospective than prospective
memory complaints, whereas the healthy older
participants and the MCI patients complained as
much about prospective as about retrospective
memory failures.
Relation of Prospective and Retrospective
Memory Complaints to Executive
Functioning in Healthy Older Adults 
and MCI Patients
To assess whether prospective memory com-
plaints were differentially associated with execu-
tive functioning for both healthy older adults and
MCI patients, Pearson product–moment correla-
tions between the PRMQ Prospective and
Retrospective Scale scores and the three applied
executive functions tests scores (i.e., Digit Span
backward scores as working memory measure,
TMT-B/A scores as task switching measure, and
third plate Victoria-Stroop Test scores as inhibi-
tion measure) were calculated separately for the
healthy older adults and the MCI patients. The
results of these analyses are displayed in Table 3.
Healthy Older Adults
The PRMQ Prospective Scale scores correlated
significantly only with the Victoria-Stroop Test
scores. Additionally, there was a marginally sig-
nificant correlation between the PRMQ
Retrospective Scale scores and the TMT-B/A
scores. Both correlations were positive and of
moderate size. This indicates (a) that healthy
older adults who rated their prospective memory
TABLE 3
Correlations Between the PRMQ Prospective (PS) and Retrospective Scale Scores (RS) and Executive Functions Tests for
Healthy Older Adults and MCI Patients
Controls MCI
PS RS PS RS
Digit Span backward –.03 (70) –.15 (69) –.03 (25) –.18 (25)
TMT-B/A .16 (71) .23 (70)† .18 (20) .60 (20)**
3rd plate Stroop .24 (70)* .15 (69) .26 (25) .10 (25)
Note: Pearson product-moment correlations are presented with n in brackets.
†p = .058. *p < .05. **p < .01.
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competence as poor tended to have a poor inhi-
bition performance and (b) that healthy older
adults who rated their retrospective memory
competence as poor tended to have a poor task
switching performance.
MCI Patients
The PRMQ Prospective Scale scores did not sig-
nificantly correlate with any of the included exec-
utive functions tests. In contrast, the PRMQ
Retrospective Scale scores correlated significantly
with the TMT B/A scores. This correlation was
positive and of moderate size, indicating that MCI
patients who rated their retrospective memory
competence as poor tended to have a poor task
switching performance.
Discussion
The aims of this study were to evaluate (a) the
usefulness of subjective prospective in compari-
son to subjective retrospective memory com-
plaints for an initial screening for MCI and (b) the
appropriateness of the proposal that awareness of
everyday prospective, but not retrospective
memory failures, is related to executive function-
ing in healthy older adults and patients with MCI.
For this purpose, 71 healthy older adults, 27 indi-
viduals with a clinical diagnosis of MCI, and 9
individuals with a clinical diagnosis of mild AD
were asked to complete the PRMQ. Their scores
on the Prospective Scale of the PRMQ were used
as a measure for subjective prospective memory
complaints and their scores on the Retrospective
Scale of the PRMQ as a measure of subjective ret-
rospective memory complaints. In addition, the
participants completed three executive functions
tests.
Since previous findings indicate that on the
one hand prospective memory is an equally sensi-
tive marker as retrospective memory for preclini-
cal and mild AD, and on the other hand awareness
of everyday prospective memory deficits is greater
than awareness of everyday retrospective memory
deficits, it was anticipated that all participant
groups would complain more about prospective
than retrospective memory failures. Additionally,
it was expected that the MCI patients would report
more prospective and retrospective memory fail-
ures than the healthy older adults. The AD
patients were expected to report more prospective
memory failures than the MCI patients. However,
due to their well-known diminished insight in this
cognitive ability, we predicted that the AD
patients would report a similar amount of retro-
spective memory failures as the MCI patients.
Interestingly, contrary to these predictions, we
found that both the healthy older adults and the
MCI patients complained as much about prospec-
tive as about retrospective memory deficits, while
the mild AD patients even complained more about
retrospective than prospective memory problems.
Additionally, neither the amount of subjective
prospective nor retrospective memory complaints
could discriminate the MCI patients from the
healthy older adults or the AD patients. However,
the difference between subjective prospective and
retrospective memory complaints distinguished
the patients with mild AD from the other two par-
ticipant groups, thus suggesting the usefulness of
assessing both subjective prospective and retro-
spective memory complaints for a screening for
mild AD.
To evaluate whether awareness of everyday
prospective memory failures is specifically related
to executive functioning in healthy older adults as
well as in MCI patients, correlations between their
scores on the Prospective and Retrospective Scale
of the PRMQ and on the three executive functions
tests were calculated separately for the two partic-
ipant groups. It was expected that for both healthy
older adults and MCI patients, their scores on the
Prospective Scale, but not on the Retrospective
Scale of the PRMQ, were related to their scores on
at least one of the executive functions tests.
Although the scores of our healthy older adults on
the Prospective Scale were correlated with their
scores on one of the three executive functions
tests, in contrast to the predictions the scores of
the MCI patients on the Prospective Scale were
not correlated to any of the included executive
functions tests. Furthermore, for both the healthy
older adults and the MCI patients, the
Retrospective Scale scores were correlated with
one of the executive functions tests. Nevertheless,
a differential pattern of associations emerged: the
Prospective Scale scores of the healthy older
adults were correlated to their scores on the inhi-
bition test, while the Retrospective Scale scores
of both the healthy older adults and the MCI
patients were correlated to their scores on the
task switching test.
With regard to previous empirical evidence,
our finding of a similar amount of subjective
prospective and retrospective memory complaints
in a group of healthy older adults is surprising. To
recap, all previous studies using the PRMQ
(Crawford et al., 2003; Kliegel & Jäger; 2006;
Mäntylä, 2003; Rönnlund et al., 2008; Singer et
al., 2006; Smith et al., 2000) reported a higher
amount of subjective prospective than retrospec-
tive memory complaints in healthy samples. A
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comparison of our data with that of Kliegel and
Jäger (2006) who applied the same PRMQ version
in another Swiss healthy sample indicates a par-
ticularly high amount of subjective retrospective
memory complaints in our sample (PRMQ
Retrospective Scale: M = 18.87, SD = 4.98 vs.
Kliegel et al.: M = 16.48, SD = 3.84), whereas the
amount of subjective prospective complaints was
very similar in both samples (PRMQ Prospective
Scale: M = 19.06, SD = 4.38 vs. Kliegel et al.: M
= 18.16, SD = 4.20). With respect to possible vari-
ables moderating this effect, one factor may be
age. Our sample of healthy adults was older (M =
73.20, SD = 7.34, 54–91 years) than Kliegel and
Jäger’s sample (M = 44.11, SD = 18.94) and the
samples of the other previous studies on the
PRMQ (Crawford et al., 2003: M = 63.62, SD =
15.59, 17–94 years ; Mäntylä, 2003: age range
35–55 years; Rönnlund et al., 2008: M = 60.58,
SD = 16.42, 35–90 years; Singer et al., 2006: M =
51, 19–85 years; Smith et al., 2000: M = 58.47,
17–93 years1). Thus, our finding of a similar
amount of subjective prospective and retrospec-
tive memory complaints in the healthy older
adults might be caused by a specific increase of
subjective retrospective memory complaints
beginning in old age, while the amount of subjec-
tive prospective memory complaints may stay
rather stable across the lifespan.
In line with this proposal, we found a signifi-
cant positive correlation between PRMQ
Retrospective Scale scores and age (r = .26, p =
.030) for the healthy older adults, whereas the
PRMQ Prospective Scale scores and age were not
significantly correlated to each other. In contrast,
in previous studies on the PRMQ with altogether
younger samples consistently no significant corre-
lations between PRMQ Retrospective Scale
scores and age were found, whereas the findings
regarding the correlation between PRMQ
Prospective Scale scores and age were very
diverse: ranging from a weak negative correlation
(r = -.21; Rönnlund et al., 2008) to no correlation
(Crawford et al., 2003) to a weak positive correla-
tion (r = .13; Singer et al., 2006).
The specific increase of subjective retrospec-
tive memory complaints in old age might be
related to the onset of retrospective memory
decline around the age of 60 years (e.g.,
Rönnlund, Nyberg, Bäckman, & Nilsson, 2005;
Schaie, 2005) or to a greater direction of attention
to retrospective memory failures from this age on
due to the generally expected onset of retrospec-
tive memory decline at this age in Western cul-
tures (Heckhausen, Dixon, & Baltes, 1989). On
development of prospective memory over the
lifespan no longitudinal data is yet available.
Cross-sectional studies comparing two extreme
age groups (adults aged between 18–30 years and
adults aged above 60 years) generally found per-
formance decrements for older adults in labora-
tory prospective memory tasks, whereas they
typically outperformed younger adults in natural-
istic prospective memory tasks (for meta-analyses
see Henry, MacLeod, Philipps, & Crawford, 2004;
Uttl, 2008). Since the latter tasks are more similar
to everyday prospective memory tasks targeted by
PRMQ items, it seems reasonable to assume that
subjective prospective memory complaints do not
increase in old age. Furthermore, the more nega-
tive functional and social consequences of
prospective as compared to retrospective memory
failures may lead to a close monitoring of
prospective memory performance from early
adulthood on and to an early development and
long practise of strategies in order to keep it on a
similar level over the lifespan. Accordingly, the
reliance on external aids, such as calendars, note-
books, reminder notes, or to-do-lists, for manag-
ing everyday prospective memory tasks is a
common practice in the normal population from
early adulthood on (Long, Cameron, Harju, Lutz,
& Means, 1999), whereas such external aids seem
to be rarely employed for everyday retrospective
memory tasks such as remembering names, object
locations, or conversations.
One possible reason why both subjective
prospective and retrospective memory complaints
did not discriminate the MCI patients from the
healthy older adults in our study may be that they
were relatively mildly impaired in retrospective
memory compared to the MCI patient groups in
previous studies (Clément et al., 2008; De Jager &
Budge, 2005; Perrotin et al., 2007) demonstrating
that MCI patients report a higher level of subjec-
tive memory complaints than healthy older adults.
In these studies, test performance of at least 1.5
standard deviations below age-adjusted norms
was used to define memory impairment, whereas
we used a cut-off score of one standard deviation
only and the mean scores of our MCI patients in
the CERAD-NAB retrospective memory subtests
were all above 1.5 standard deviations below age-
adjusted norms. It might be possible that because
of their mild impairment and an appropriate use of
external aids, our MCI patients were still able to
manage everyday retrospective and prospective
memory tasks as well as healthy older adults.
Moreover, the MCI patients may not have com-
plained more about prospective than retrospective
memory deficits because they still put more effort
into managing prospective memory tasks and
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were, due to their greater practise in using exter-
nal aids for this type of everyday memory task,
more successful in accomplishing them. Findings
by Marsh, Hicks, and Landau (1998) indicate that
mild retrospective memory deficits can be in fact
compensated by the use of daily planners. They
reported that young healthy adults who habitually
used daily planners for managing their everyday
prospective memory tasks had worse retrospective
memory abilities than young healthy adults who
did not use daily planners, but were able to com-
plete a similar amount of prospective memory
tasks during one week. Furthermore, recently
improvements in the functional ability of MCI
patients after a short training in the use of an elec-
tronic calendar system have been demonstrated
(Greenaway, Hanna, Lepore, & Smith, 2008),
showing that MCI patients, despite their mild cog-
nitive impairments, are able to successfully apply
external memory aids.
In contrast to the MCI patients, the mild AD
patients in this study were severely impaired in
retrospective memory tasks and had also other
cognitive deficits. This may have hindered them in
the appropriate use of external memory aids.
Therefore, the finding that they reported a similar
level of prospective and retrospective memory
failures as the healthy older adults and the MCI
patients seems to be most likely caused by a
diminished insight in the severity of their prospec-
tive and retrospective memory impairment.
However, since they reported more retrospective
than prospective memory impairments, their
insight in their retrospective memory competence
seems to be more preserved than their insight in
their prospective memory impairments. On the
other hand, Smith et al. (2000) reported that carers
of AD patients are more frustrated about the
patients’ prospective than retrospective memory
failures. Therefore, they may relieve the AD
patients from many everyday prospective memory
tasks. Consequently, the AD patients may indeed
experience fewer everyday prospective than retro-
spective memory failures. Alternatively, it might
be easier for the AD patients and their carers to
identify and accept retrospective memory failures
since their physicians presented them as the core
symptom of the disease, whereas they did not
mention prospective memory failures because of
their little familiarity with this type of episodic
memory.
In our study, we could not confirm Mäntylä’s
(2003) proposal of a differential relation of sub-
jective prospective memory complaints to execu-
tive functioning, since only for the healthy older
adults were the PRMQ Prospective Scale scores
correlated with an executive functions test, while
the PRMQ Retrospective Scale scores were corre-
lated to an executive functions test for both the
healthy older adults and the MCI patients. This
might be caused by the fact that the Retrospective
Scale included a similar amount of questions
relating to tasks demanding self-initiated retrieval
as the Prospective Scale. In line with this sugges-
tion, Dubreuil, Adam, Bier, and Gagnon (2007)
could not find a significant correlation between
subjective mainly retrospective memory com-
plaints with a classical retrospective memory task.
However, when they separated controlled and
automatic memory processes in this task with the
Process Dissociation Procedure, they could
demonstrate a significant correlation between the
subjective memory complaints and the controlled
processes. Subjective prospective memory com-
plaints may rather be related to planning instead
of working memory, inhibition, or task switching
that were measured with the executive functions
tests included in this study. In everyday life,
people may indeed try to schedule their intended
activities so that interruptions of or switches
between activities are avoided and, therefore, their
timely execution does not depend critically on
inhibition or task switching abilities.
A clear limitation of this study is the small
sample size of the mild AD patients, thus dimin-
ishing the power of the statistical analyses, and
particularly challenging nonsignificant findings.
However, for the main effect of group on subjec-
tive prospective and retrospective memory com-
plaints, as well as for the difference between these
two types of memory complaints in the healthy
older adults and in the MCI patients, the observed
effect sizes were very small, whereas a medium
effect size was found for the difference in the mild
AD patients, indicating a replication of our find-
ings with larger samples would be worthwhile.
Another limitation of this study is the use of con-
venience samples. The MCI and mild AD patients
were recruited from a gerontopsychiatric hospital
and thus may have been more aware of their
memory problems than similarly affected individ-
uals who do not seek medical advice. The healthy
older adults were community-dwelling volun-
teers. They may have a better memory and thus
may complain less about memory failures than the
general older population. Consequently, the distri-
bution of the PRMQ to a population-based sample
of older adults would be desirable in the future.
Furthermore, individuals with MCI constitute a
heterogeneous group with regard to cognitive pro-
file and conversion to AD. At the present, a lot of
research is dedicated to determining the predictive
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power for AD of different cognitive subtypes of
MCI (Petersen & Negash, 2008). In future
research, it would be useful to include a cogni-
tively more homogeneous sample of patients with
a subtype of MCI that has high predictive power
for AD. Moreover, we have explained our findings
with differences between healthy younger and
older adults, MCI patients, and AD patients in
prospective and retrospective memory ability,
awareness for failures of, the use of external aids
for, or everyday demands on prospective and ret-
rospective memory, but did not record most of
these variables, or if so, not in all groups. To test
the validity of our explanations, in a follow-up
study the inclusion of an additional sample of
healthy young or middle-aged adults and the mea-
surement of the aforementioned variables in all
included groups would be desirable. Furthermore,
it would be interesting to directly target insight in
prospective and retrospective memory in MCI
patients and mild AD patients by comparing their
own ratings on the PRMQ with that of their care-
givers. For this purpose, the proxy-rating version
of the PRMQ (Crawford, Henry, Ward, & Blake,
2006) could be applied.
In conclusion, our results indicate that the
assessment of subjective prospective and retro-
spective memory complaints with the Prospective
and Retrospective Scales of the PRMQ is particu-
larly useful for the discrimination of mild AD
patients from healthy older adults and MCI
patients. However, the mild AD patients could not
be distinguished from the other groups by a
greater amount of prospective or retrospective
memory complaints, but by a greater amount of
retrospective relative to prospective memory com-
plaints. Furthermore, our data point to a change of
the relation between subjective prospective and
retrospective memory complaints in healthy old
age with a relative increase in retrospective
memory complaints. However, for a deeper under-
standing of self-reports on prospective and retro-
spective memory competence in normal adults,
MCI patients, and AD patients more research on
variables influencing them is needed.
Endnote
1 All available data reported.
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